By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Roquefort Therapeutics plc

Roquefort Therapeutics plc (ROQ.L)

LSE Currency in GBP
£1.55
-£0.15
-9.68%
Last Update: 16 Jul 2025, 15:35
£2.44M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
£1.08 - £6.78
52 Week Range

ROQ.L Stock Price Chart

Explore Roquefort Therapeutics plc interactive price chart. Choose custom timeframes to analyze ROQ.L price movements and trends.

There is nothing to show.

ROQ.L Company Profile

Discover essential business fundamentals and corporate details for Roquefort Therapeutics plc (ROQ.L) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

22 Mar 2021

Employees

7.00

CEO

Stephen Paul West CA

Description

Roquefort Therapeutics plc operates as a biotechnology research company. The company engages in the research and development of drugs targeting Midkine, a circulating growth factor protein and pro-inflammatory mediator for the treatment of cancer. Roquefort Therapeutics plc was incorporated in 2020 and is headquartered in London, the United Kingdom.

ROQ.L Financial Timeline

Browse a chronological timeline of Roquefort Therapeutics plc corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 28 Apr 2026

Upcoming earnings on 25 Sept 2025

Earnings released on 30 Apr 2025

Earnings released on 27 Sept 2024

EPS came in at -£0.00, while revenue for the quarter reached £2.70K.

Earnings released on 26 Apr 2024

EPS came in at -£0.01.

Earnings released on 27 Sept 2023

EPS came in at -£0.01, while revenue for the quarter reached £200.00K.

Earnings released on 5 Jun 2023

EPS came in at -£0.01.

Earnings released on 30 Jun 2022

EPS came in at -£0.02.

Earnings released on 31 Dec 2021

EPS came in at -£0.01, while revenue for the quarter reached £719.00.

Earnings released on 30 Jun 2021

EPS came in at -£0.02.

Earnings released on 30 Nov 2020

EPS came in at -£0.00.

ROQ.L Stock Performance

Access detailed ROQ.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

There is nothing to show.
ROQ.L
Company Name
Exchange
Market Currency
Report Currency
Price
Price Change
Percentage Change
50-Day Average Price
200-Day Average Price
Trading Volume
Market Capitalization
ROQ.L
2025
2024
2023
2022
2021
Revenue
Gross Profit
Earnings Before Interest and Taxes (EBIT)
Net Income
Total Current Assets
Total Assets
Total Liabilities
Net Debt
Total Equity
Cash Flow from Operating
Cash Flow from Investing
Cash Flow from Financing
Free Cash Flow

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More